Amarin Corporation PLC
NASDAQ:AMRN

Watchlist Manager
Amarin Corporation PLC Logo
Amarin Corporation PLC
NASDAQ:AMRN
Watchlist
Price: 15.59 USD 2.3% Market Closed
Market Cap: 323m USD

Operating Margin
Amarin Corporation PLC

-44.4%
Current
-14%
Average
-5.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-44.4%
=
Operating Profit
-95m
/
Revenue
214.1m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
IE
Amarin Corporation PLC
NASDAQ:AMRN
323m USD
-44%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
336.6B USD
30%
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
325.9B USD
-2 834%
US
Amgen Inc
NASDAQ:AMGN
165.8B USD
25%
US
Gilead Sciences Inc
NASDAQ:GILD
141.4B USD
38%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
122.3B USD
38%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
128.6B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
61.9B USD
29%
US
Seagen Inc
F:SGT
39.3B EUR
-33%

Amarin Corporation PLC
Glance View

Market Cap
323m USD
Industry
Biotechnology

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. The firm is focused on the commercialization and development of therapeutics for cardiovascular disease management. The firm operates through the development and commercialization of Vascepa segment. Its lead product, Vascepa (icosapent ethyl) capsule for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The firm sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

AMRN Intrinsic Value
19.55 USD
Undervaluation 20%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-44.4%
=
Operating Profit
-95m
/
Revenue
214.1m
What is the Operating Margin of Amarin Corporation PLC?

Based on Amarin Corporation PLC's most recent financial statements, the company has Operating Margin of -44.4%.

Back to Top